Rhodopsin Antibody (Rabbit mAb) [M1K19]

Catalog No.: F5305

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:30
    1:32000
    Application
    WB, IP, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    39 kDa 35-150 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Rhodopsin Antibody (Rabbit mAb) [M1K19] detects endogenous levels of total Rhodopsin protein.
    Clone
    M1K19
    Synonym(s)
    OPN2, RHO, Rhodopsin, Opsin-2
    Background
    Rhodopsin, also called visual purple, is a prototypical G‑protein‑coupled receptor of the seven‑transmembrane helix family that serves as the primary photopigment in rod photoreceptors and initiates the phototransduction cascade responsible for scotopic vision. The protein consists of an opsin apoprotein embedded in the disk membranes of the rod outer segment, covalently linked via a Schiff base to the 11‑cis retinal chromophore, and carries characteristic GPCR structural elements such as a conserved disulfide bond, N‑terminal glycosylation sites, and palmitoylated cysteines in the C‑terminal tail that stabilize its conformation and membrane localization. Absorption of a photon induces isomerization of 11‑cis retinal to all‑trans retinal and drives rhodopsin from its inactive ground state through a series of intermediates to the active Meta II form, which adopts a conformation that enables high‑affinity coupling to the heterotrimeric G protein transducin and catalyzes exchange of GDP for GTP on the transducin α‑subunit. Activated transducin stimulates cGMP phosphodiesterase, leading to a drop in cytoplasmic cGMP and closure of cGMP‑gated cation channels, which results in hyperpolarization of the rod plasma membrane and generation of the electrical signal that is transmitted to downstream retinal neurons. Termination and resetting of this signaling cycle rely on phosphorylation of the rhodopsin C‑terminal tail by rhodopsin kinase followed by arrestin binding, which blocks further transducin activation, while the all‑trans retinal is released and converted back to 11‑cis retinal through the retinoid cycle before reattachment to opsin. The arrangement of transmembrane helices, the retinal binding pocket, and cytoplasmic loops enables specific amino acid substitutions to alter receptor stability, retinal interaction, and G‑protein coupling, which provides a basis for diverse disease‑associated variants. Mutations in the rhodopsin gene account for a substantial fraction of autosomal dominant retinitis pigmentosa, and different mutant classes can cause degeneration through protein misfolding and aggregation, mislocalization away from the outer segment disks, production of toxic by‑products during abnormal chromophore handling, or aberrant signaling activity that disturbs photoreceptor homeostasis. Other rhodopsin mutations cluster near the retinal attachment site and produce constitutive activity without major structural degeneration, a pattern linked to congenital stationary night blindness, where rod signaling is chronically desensitized, but photoreceptors remain largely intact.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください